Safety and performance of a lipiodol-resistant mixing and injection system in conventional trans-arterial chemoembolization: A post-market clinical follow-up

Liver cancer is the sixth most diagnosed cancer and the third leading cause of cancer-related death worldwide. Hepatocellular carcinoma (HCC) represents about 75–85 % of primary liver cancers [1].

Read the full article on ejradiology.com